Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Aballéa · SciRah

Researcher profile · Semantic Scholar

S. Aballéa

Share profile

S. Aballéa — researcher profile on SciRah

h-index: 28
Works: 318
Citations: 2,832

Most-cited papers

Measuring health-related quality of life in young children: how far have we come?
N. Germain, S. Aballéa, M. Toumi
2019Journal of Market Access & Health Policy109 citations Open access
Semantic Scholar
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
K. Jabłońska, S. Aballéa, M. Toumi
2021medRxiv93 citations Open access
Semantic Scholar
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
B. Macabeo, Arthur Quenéchdu, S. Aballéa, Clément François +2 more
2024Journal of Market Access & Health Policy37 citations Open access
Semantic Scholar
A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients
Vanessa Taieb, H. Ikeoka, F. Ma, K. Borkowska +3 more
2019Current Medical Research and Opinion36 citations Open access
Semantic Scholar
Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
L. Chachoua, M. Dabbous, C. François, C. Dussart +2 more
2020Frontiers in Medicine29 citations Open access
Semantic Scholar
Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients – a Bayesian network meta-analysis
Vanessa Taieb, Hidetoshi Ikeoka, P. Wojciechowski, K. Jabłońska +3 more
2020Current Medical Research and Opinion28 citations Open access
Semantic Scholar
Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France
C. Chouaid, N. Germain, G. de Pouvourville, S. Aballéa +6 more
2019Current Medical Research and Opinion25 citations Open access
Semantic Scholar
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
S. Aballéa, K. Thokagevistk, R. Velikanova, S. Simoens +12 more
2020Journal of Market Access & Health Policy24 citations Open access
Semantic Scholar
Risk factors for cervical cancer in women in China: A meta-model
S. Aballéa, E. Beck, Xiao Cheng, N. Demarteau +4 more
2020Women's Health21 citations Open access
Semantic Scholar
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies
O. Dabbous, L. Chachoua, S. Aballéa, M. Sivignon +5 more
2022Advances in Therapy20 citations Open access
Semantic Scholar
Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population
M. Toumi, A. Millier, O. Cristeau, Katia Thokagevistk-Desroziers +2 more
2020Frontiers in Medicine18 citations Open access
Semantic Scholar
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
M. Pochopień, E. Paterak, E. Clay, J. Janik +3 more
2021Journal of Market Access & Health Policy17 citations Open access
Semantic Scholar
Factors influencing the COVID-19 daily deaths' peak across European countries
K. Jabłońska, S. Aballéa, M. Toumi
2020medRxiv17 citations Open access
Semantic Scholar
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
M. Pochopień, A. Beiderbeck, P. McEwan, R. Zur +2 more
2019BMC Health Services Research16 citations Open access
Semantic Scholar
How pet owners choose antiparasitic treatments for their dogs: A discrete choice experiment.
M. Bebrysz, Andrea K. Wright, M. Greaves, Dominick Rathwell Deault +3 more
2021Preventive Veterinary Medicine15 citations Open access
Semantic Scholar
Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
M. Toumi, S. Aballéa
2020Journal of Market Access & Health Policy15 citations Open access
Semantic Scholar
Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan
M. Dronova, H. Ikeoka, Naoya Itsumura, N. Hirotsu +5 more
2021Current Medical Research and Opinion13 citations Open access
Semantic Scholar
Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials
R. Klamroth, P. Wojciechowski, S. Aballéa, F. Diamand +6 more
2020Journal of Blood Medicine13 citations Open access
Semantic Scholar
Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysis
Damien Etchecopar-Etchart, D. Yon, Piotr Wojciechowski, S. Aballéa +3 more
2024EClinicalMedicine12 citations Open access
Semantic Scholar
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal
M. Toumi, O. Dabbous, S. Aballéa, Michael F. Drummond +5 more
2023Expert review of pharmacoeconomics & outcomes research12 citations Open access
Semantic Scholar
Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: a systematic review.
T. Qiu, M. Pochopień, E. Hanna, S. Liang +4 more
2022Regenerative medicine11 citations
Semantic Scholar
Neurologists’ preferences for device-aided therapy for advanced Parkinson’s disease in Japan
S. Fujioka, Takayasu Mishima, Toru Yamazaki, M. Bebrysz +6 more
2022Current Medical Research and Opinion11 citations Open access
Semantic Scholar
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B‐LONG using haemophilia‐specific quality of life questionnaires
J. Astermark, C. Hermans, M. Ezzalfani, S. Aballéa +3 more
2021Haemophilia11 citations Open access
Semantic Scholar
Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study
J. Pasi, C. Hermans, Z. Hakimi, J. Nazir +3 more
2022Therapeutic Advances in Hematology10 citations Open access
Semantic Scholar
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
K. Jabłońska, S. Aballéa, P. Auquier, M. Toumi
2021medRxiv10 citations Open access
Semantic Scholar
Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan.
A. Skrzeczek, H. Ikeoka, N. Hirotsu, A. Ansaripour +4 more
2020Journal of Infection and Chemotherapy9 citations Open access
Semantic Scholar
Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials
J. Astermark, P. Wojciechowski, S. Aballéa, Z. Hakimi +2 more
2021Journal of Blood Medicine8 citations Open access
Semantic Scholar
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies
M. Pochopień, T. Qiu, S. Aballéa, E. Clay +1 more
2021Expert review of pharmacoeconomics & outcomes research8 citations
Semantic Scholar
Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe
M. Mancuso, G. Castaman, Michał Pochopień, S. Aballéa +4 more
2022Journal of Medical Economics7 citations Open access
Semantic Scholar
Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK
Nana Kragh, A. Tytuła, Michał Pochopień, S. Aballéa +5 more
2022European Journal of Haematology6 citations Open access
Semantic Scholar
A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: whether a specific approach is justified to tackle the challenges?
Tingting Qiu, S. Aballéa, M. Pochopień, M. Toumi +2 more
2024International Journal of Technology Assessment in Health Care5 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
M. Pochopień, J. Dziedzic, S. Aballéa, Emilie Clay +3 more
2024Journal of Market Access & Health Policy4 citations Open access
Semantic Scholar
Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth
Mondher Toumi, Bruno Falissard, Asma Jouini, S. Aballéa +1 more
2025Journal of Market Access & Health Policy3 citations Open access
Semantic Scholar
Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model
Junwen Zhou, Aurélie Millier, S. Aballéa, Clément François +5 more
2024British Journal of Psychiatry3 citations Open access
Semantic Scholar
EE562 Cost-Effectiveness of the Dengue Vaccine TAK-003 in Thailand
Jie Shen, E. Kharitonova, S. Biswal, M. Sharma +6 more
2023Value in Health3 citations
Semantic Scholar
Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the Mark
S. Aballéa, M. Toumi, Piotr Wojciechowski, Emilie Clay +9 more
2026Journal of Market Access & Health Policy2 citations Open access
Semantic Scholar
The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art
Beata Smela, M. Toumi, S. Aballéa, S. Simoens +5 more
2026Journal of Market Access & Health Policy2 citations Open access
Semantic Scholar
[A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients].
Vanessa Taieb, H. Ikeoka, F. Ma, K. Borkowska +3 more
2020Терапевтический архив2 citations Open access
Semantic Scholar
Can We Trust PAICs in Rare Diseases? Methodological Challenges and Limitations
M. Parkitny, S. Aballéa, Piotr Wojciechowski, M. Toumi
2026Journal of Market Access & Health Policy1 citations Open access
Semantic Scholar
MSR27 An Extension of Unanchored Matching-Adjusted Indirect Comparison to Verify the Results of the Comparisons Between Poorly Overlapping Studies
M. Parkitny, P. Wojciechowski, S. Aballéa, M. Toumi
2024Value in Health1 citations
Semantic Scholar
MSR127 Synthetic Data Generation: A New Approach for Population-Adjusted Indirect Treatment Comparisons Tested in Diabetic Macular Edema
S. Aballéa, I. Chebuniaev, M. Parkitny, P. Wojciechowski +1 more
2024Value in Health1 citations
Semantic Scholar
EE122 From Quality-Adjusted Life Years (QALY) to Equal Value of Life Years (evLY): A Study on Non-Alcoholic Steatohepatitis (NASH) Subpopulations
M. Żemojdzin, M. Pochopień, J. Dziedzic, E. Clay +2 more
2024Value in Health1 citations
Semantic Scholar
DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
Jie Shen, E. Kharitonova, S. Biswal, M. Sharma +5 more
2023International Journal of Infectious Diseases1 citations Open access
Semantic Scholar
MSR26 Review of Existing AI-Based Automatic Tools for Evidence Synthesis
W. Margas, S. Barbier, M. Damentko, P. Wojciechowski +3 more
2022Value in Health1 citations Open access
Semantic Scholar
EE283 Cost-Effectiveness Analysis of Cell-Based Therapy for Patients with Non-Alcoholic Fatty Liver Disease
S. Aballéa, P. Karwala, I. Żerda, M. Toumi +4 more
2022Value in Health1 citations Open access
Semantic Scholar
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
Ru Han, S. Liang, C. François, S. Aballéa +2 more
2021Journal of Market Access & Health Policy1 citations Open access
Semantic Scholar
PCN297 ATTRIBUTE DEVELOPMENT FOR A DISCRETE CHOICE EXPERIMENT (DCE) EXPLORING WILLINGNESS TO PAY (WTP) FOR CURING CANCER
N. Germain, S. Aballéa, M. Desroches, M. Toumi
2019Value in Health1 citations Open access
Semantic Scholar
Analysis of How the Term “Shall” Is Understood and Applied to the EU-HTA Regulation
M. Toumi, S. Aballéa, B. Fallissard, Claude Dussart +2 more
2026Journal of Market Access & Health Policy0 citations Open access
Semantic Scholar
HTA272 Predicting SMC Appraisal Outcomes Using Machine Learning: A Model to Support Early Market Access Strategy
S. Aballéa, Zeineb Hammami, Przemyslaw Lipka, Bechir Mlika +1 more
2025Value in Health0 citations
Semantic Scholar
HTA19 The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Marta Wilk, K. Ben Abdallah, L. Chachoua, S. Aballéa +1 more
2025Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Toumi×19
Invite
M. Toumi — researcher profile on SciRah
M. Pochopień×8
Invite
M. Pochopień — researcher profile on SciRah
Z. Hakimi×6
Invite
Z. Hakimi — researcher profile on SciRah
J. Nazir×6
Invite
J. Nazir — researcher profile on SciRah

×6

Invite

M. Toumi — researcher profile on SciRah

Invite

N. Hirotsu — researcher profile on SciRah

Mondher Toumi×5

Invite

Mondher Toumi — researcher profile on SciRah

K. Jabłońska×4

Invite

K. Jabłońska — researcher profile on SciRah

Laurent Boyer×4

Invite

Laurent Boyer — researcher profile on SciRah

Invite

H. Ikeoka — researcher profile on SciRah

Invite

E. Clay — researcher profile on SciRah

Invite

N. Germain — researcher profile on SciRah